Atevirdine mesilate or mesylate

InformationAmenamevir Amenamevir (ASP2151) is a potent helicase-primase inhibitor and a novel class of antiviral agent.Targetshelicase-primaseIn vitroASP2151 inhibited the in vitro replication of HSV-1. The mean EC50s of ASP2151 against HSV-1 and

InformationAmenamevir Amenamevir (ASP2151) is a potent helicase-primase inhibitor and a novel class of antiviral agent.Targetshelicase-primaseIn vitroASP2151 inhibited the in vitro replication of HSV-1. The mean EC50s of ASP2151 against HSV-1 and

InformationAmenamevir Amenamevir (ASP2151) is a potent helicase-primase inhibitor and a novel class of antiviral agent.Targetshelicase-primaseIn vitroASP2151 inhibited the in vitro replication of HSV-1. The mean EC50s of ASP2151 against HSV-1 and

InformationAmenamevir Amenamevir (ASP2151) is a potent helicase-primase inhibitor and a novel class of antiviral agent.Targetshelicase-primaseIn vitroASP2151 inhibited the in vitro replication of HSV-1. The mean EC50s of ASP2151 against HSV-1 and

InformationAmenamevir Amenamevir (ASP2151) is a potent helicase-primase inhibitor and a novel class of antiviral agent.Targetshelicase-primaseIn vitroASP2151 inhibited the in vitro replication of HSV-1. The mean EC50s of ASP2151 against HSV-1 and

InformationAmenamevir Amenamevir (ASP2151) is a potent helicase-primase inhibitor and a novel class of antiviral agent.Targetshelicase-primaseIn vitroASP2151 inhibited the in vitro replication of HSV-1. The mean EC50s of ASP2151 against HSV-1 and

DEHP-free and latex free. Packaged in poly pouch.

DEHP-free and latex free. Packaged in poly pouch.

DEHP-free and latex free. Packaged in poly pouch.

DEHP-free and latex free. Packaged in poly pouch.

Immunogen Peptide with sequence C-ENSEQANTQDSG from the internal region of the protein sequence according to NP_004398.1: NP_001073380.

Specificity Reacts with the Echovirus 4, 6, 9, 11, 30 and 34. CROSS REACTIVITIES: No cross-reactivity to CMV, HSV 1 &amp: 2, Para 1, 2, &amp: 3, Poliovirus 1 &amp: 3 or Mumps.